Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Management > Seeking Disagreement - How We Use Questions To Get More Commitment, Learning And Better Results

Tags

  • devices
  • quickly
  • product
  • combination products
  • concerns about

  • Links

  • Form 1040EZ Tax Basics
  • Is Inflation Harmful
  • Payday Loans - What Do I Get and How Much Will It Cost?
  • Digg It - Seeking Disagreement - How We Use Questions To Get More Commitment, Learning And Better Results

    How we use questions to get more commitment, learning and better results.

    Two weeks ago, Sue McKinney, Peg Carlson and I spent four d
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ays training a group of internal Continuous Improvement consultants. They noticed two things about us and our approach:

    -We ask a lot
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    of genuinely curious questions
    -We actively seek disagreement and difference

    Many of them noticed the opposite patterns in them
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    elves! As they practiced their newfound skills, we all noticed that they would often advocate for something and then ask questions lik
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    e "Are you ok with that?", "Am I right?" or "Do you agree?" We also noticed they were silently hoping that they'd get quick agreement
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    so they could move on.

    We talked with them about their questions. We decided that their questions were likely to solicit agreement or
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    similar views. They also made it harder for others to openly disagree.

    We suggested a different way of thinking: if they genuinely wa
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    nted solutions that people were internally committed to and they wanted them quickly, they would be better off saying what they were t
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    hinking, then actively seeking disagreement.

    Time and again, we've learned that if people disagree or see things differently, we save
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    time by discovering their views as quickly as possible. We suggest you ask questions that actively seek disagreement or that encourage
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    people to respond with whatever they're naturally thinking. Here are some examples of each:

    "Seeking Disagreement" questions:
    "
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    I'd like to use [x] as a vendor. Do you have any concerns about [x]?"
    "I'd like to... Does anyone see any problems with what I'm
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    uggesting?"
    "I think you have concerns about this project. Am I off base?"
    "I think we'd save time by building an agenda. Ar
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    e you seeing that differently?"
    "I think this market will be profitable because.... What flaws, if any, do you see in my logic?"
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen

    "Natural Thinking" questions:
    "I think production in unit A has slowed. What do you think?"
    "I'm concerned that we don't ha
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    e enough support from Jim and his team. What's your reaction to that?"
    "Sounds like you think [x] is the best way to go. What is
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    it that's important to you about [x]?"
    "It sounds like we've missed our deadline. Have I done anything to contribute to this prob
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    lem?"

    We've found that getting these questions out your mouth in a believable way requires you to be genuinely interested in surfacin
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    differences and disagreement. If you aren't, they will probably come across as canned, perfunctory, or even manipulative.

    What are y
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    our reactions to all of this? Please come to the Mutual Learning Action Group and share them with us and your peers.

    © 2005 Matt Bean


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/23319/diggit-Seeking-Disagreement--How-We-Use-Questions-To-Get-More-Commitment-Learning-And-Better-Results.html">Seeking Disagreement - How We Use Questions To Get More Commitment, Learning And Better Results</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/23319/diggit-Seeking-Disagreement--How-We-Use-Questions-To-Get-More-Commitment-Learning-And-Better-Results.html]Seeking Disagreement - How We Use Questions To Get More Commitment, Learning And Better Results[/url]

    Related Articles:

    Globalism: What Does It Mean?

    Computer Consulting: Excellent Customer Service Inspires Growth

    Fundraising for Small Groups

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com